 Jeffrey Glasheen
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 15 | 2022 | 229 | 3.040 |
Why?
| | Internal Medicine | 10 | 2016 | 247 | 1.870 |
Why?
| | Internship and Residency | 9 | 2022 | 1053 | 1.560 |
Why?
| | Hospital Medicine | 3 | 2022 | 91 | 1.280 |
Why?
| | Warfarin | 6 | 2011 | 147 | 1.250 |
Why?
| | Leadership | 3 | 2022 | 357 | 1.220 |
Why?
| | Academic Medical Centers | 7 | 2017 | 481 | 1.210 |
Why?
| | Quality Improvement | 6 | 2022 | 1103 | 1.120 |
Why?
| | Anticoagulants | 5 | 2008 | 637 | 0.900 |
Why?
| | Career Mobility | 2 | 2017 | 68 | 0.880 |
Why?
| | Education, Medical, Undergraduate | 2 | 2021 | 176 | 0.860 |
Why?
| | Ofloxacin | 4 | 2008 | 24 | 0.850 |
Why?
| | Levofloxacin | 4 | 2008 | 25 | 0.840 |
Why?
| | Hospitalization | 5 | 2023 | 2070 | 0.760 |
Why?
| | Models, Educational | 2 | 2015 | 88 | 0.750 |
Why?
| | Hospital Costs | 2 | 2011 | 114 | 0.700 |
Why?
| | Hemorrhage | 3 | 2008 | 678 | 0.580 |
Why?
| | Education, Medical | 3 | 2015 | 244 | 0.540 |
Why?
| | Clinical Competence | 3 | 2015 | 1017 | 0.520 |
Why?
| | Mentors | 4 | 2022 | 178 | 0.500 |
Why?
| | Stroke | 5 | 2015 | 1071 | 0.500 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 100 | 0.490 |
Why?
| | Patient Discharge | 5 | 2016 | 857 | 0.480 |
Why?
| | Patient Handoff | 1 | 2015 | 31 | 0.460 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 94 | 0.460 |
Why?
| | Medicaid | 2 | 2016 | 433 | 0.460 |
Why?
| | Efficiency | 2 | 2011 | 91 | 0.440 |
Why?
| | International Normalized Ratio | 4 | 2008 | 46 | 0.420 |
Why?
| | Faculty, Medical | 3 | 2016 | 264 | 0.410 |
Why?
| | Practice Patterns, Physicians' | 2 | 2011 | 1266 | 0.400 |
Why?
| | Perception | 1 | 2015 | 340 | 0.390 |
Why?
| | Job Satisfaction | 3 | 2022 | 203 | 0.370 |
Why?
| | Hospitals | 2 | 2023 | 637 | 0.370 |
Why?
| | Medicare | 3 | 2015 | 720 | 0.360 |
Why?
| | Hospitals, University | 1 | 2011 | 179 | 0.350 |
Why?
| | Polypharmacy | 1 | 2011 | 84 | 0.340 |
Why?
| | Cooperative Behavior | 2 | 2011 | 433 | 0.330 |
Why?
| | Patient Readmission | 2 | 2013 | 667 | 0.320 |
Why?
| | Humans | 42 | 2023 | 129650 | 0.320 |
Why?
| | Ischemic Attack, Transient | 1 | 2009 | 60 | 0.300 |
Why?
| | Inservice Training | 1 | 2009 | 114 | 0.300 |
Why?
| | Delivery of Health Care | 2 | 2021 | 894 | 0.290 |
Why?
| | Curriculum | 5 | 2022 | 917 | 0.280 |
Why?
| | Burnout, Professional | 3 | 2011 | 410 | 0.280 |
Why?
| | Dysentery | 1 | 2007 | 1 | 0.280 |
Why?
| | Anti-Bacterial Agents | 2 | 2008 | 1717 | 0.280 |
Why?
| | Physicians | 2 | 2015 | 865 | 0.270 |
Why?
| | Patient Care Team | 1 | 2011 | 605 | 0.260 |
Why?
| | Career Choice | 2 | 2022 | 207 | 0.250 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2008 | 152 | 0.240 |
Why?
| | Communication | 1 | 2011 | 846 | 0.240 |
Why?
| | Drug Interactions | 4 | 2008 | 394 | 0.230 |
Why?
| | Acidosis, Lactic | 1 | 2005 | 46 | 0.230 |
Why?
| | Burkitt Lymphoma | 1 | 2005 | 56 | 0.230 |
Why?
| | Feces | 1 | 2007 | 440 | 0.220 |
Why?
| | Length of Stay | 3 | 2016 | 1127 | 0.220 |
Why?
| | Blood Pressure | 2 | 2009 | 1736 | 0.220 |
Why?
| | Stress, Psychological | 1 | 2011 | 1066 | 0.200 |
Why?
| | Hypercapnia | 1 | 2002 | 50 | 0.200 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 248 | 0.200 |
Why?
| | Hypothyroidism | 1 | 2002 | 70 | 0.200 |
Why?
| | Academies and Institutes | 1 | 2022 | 49 | 0.190 |
Why?
| | Organizational Innovation | 2 | 2015 | 139 | 0.180 |
Why?
| | Primary Health Care | 1 | 2011 | 1680 | 0.180 |
Why?
| | Emergency Service, Hospital | 1 | 2011 | 1902 | 0.170 |
Why?
| | Hypoglycemia | 1 | 2005 | 427 | 0.170 |
Why?
| | Risk Assessment | 1 | 2009 | 3240 | 0.160 |
Why?
| | Inpatients | 1 | 2023 | 467 | 0.160 |
Why?
| | United States | 7 | 2016 | 13903 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 273 | 0.150 |
Why?
| | Program Evaluation | 1 | 2022 | 875 | 0.140 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5066 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2021 | 850 | 0.130 |
Why?
| | Insurance, Health | 2 | 2015 | 267 | 0.130 |
Why?
| | Students | 1 | 2021 | 580 | 0.130 |
Why?
| | Uncompensated Care | 1 | 2015 | 19 | 0.120 |
Why?
| | Medically Uninsured | 1 | 2015 | 127 | 0.120 |
Why?
| | Retrospective Studies | 7 | 2021 | 14518 | 0.110 |
Why?
| | Hospitals, Special | 1 | 2013 | 9 | 0.110 |
Why?
| | Aged | 8 | 2015 | 22103 | 0.110 |
Why?
| | Mentoring | 1 | 2016 | 131 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1488 | 0.100 |
Why?
| | Female | 13 | 2022 | 68776 | 0.100 |
Why?
| | Workload | 2 | 2011 | 153 | 0.100 |
Why?
| | Male | 12 | 2016 | 63681 | 0.090 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 212 | 0.090 |
Why?
| | Risk Factors | 5 | 2015 | 9765 | 0.090 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 275 | 0.090 |
Why?
| | Health Services for the Aged | 1 | 2011 | 72 | 0.090 |
Why?
| | Specialties, Surgical | 1 | 2011 | 73 | 0.090 |
Why?
| | Time Factors | 2 | 2011 | 6556 | 0.090 |
Why?
| | Cerebral Hemorrhage | 1 | 2011 | 107 | 0.080 |
Why?
| | Patient Safety | 1 | 2013 | 287 | 0.080 |
Why?
| | Blood Cell Count | 1 | 2009 | 52 | 0.080 |
Why?
| | Speech Disorders | 1 | 2009 | 34 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 222 | 0.080 |
Why?
| | Adult | 7 | 2022 | 35576 | 0.080 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2007 | 89 | 0.080 |
Why?
| | Data Collection | 1 | 2011 | 650 | 0.080 |
Why?
| | Histamine H1 Antagonists | 1 | 2008 | 29 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2009 | 102 | 0.070 |
Why?
| | Neurology | 1 | 2009 | 103 | 0.070 |
Why?
| | Models, Organizational | 1 | 2008 | 146 | 0.070 |
Why?
| | Geriatrics | 1 | 2008 | 81 | 0.070 |
Why?
| | Carotid Arteries | 1 | 2009 | 196 | 0.070 |
Why?
| | Disabled Persons | 1 | 2009 | 140 | 0.070 |
Why?
| | Benzodiazepines | 1 | 2008 | 136 | 0.070 |
Why?
| | Internet | 1 | 2011 | 617 | 0.070 |
Why?
| | Critical Care | 1 | 2011 | 553 | 0.060 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 175 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 218 | 0.060 |
Why?
| | Antidepressive Agents | 1 | 2008 | 228 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 569 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 608 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 23 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 37 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 663 | 0.060 |
Why?
| | Ultrasonography | 1 | 2009 | 716 | 0.060 |
Why?
| | Lipids | 1 | 2009 | 625 | 0.060 |
Why?
| | Azithromycin | 1 | 2005 | 93 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 376 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2005 | 300 | 0.060 |
Why?
| | Tumor Burden | 1 | 2005 | 286 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1952 | 0.050 |
Why?
| | Thrombosis | 1 | 2007 | 343 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2007 | 485 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2005 | 485 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 5420 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 718 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2011 | 5406 | 0.050 |
Why?
| | Referral and Consultation | 1 | 2008 | 732 | 0.050 |
Why?
| | Administration, Oral | 1 | 2005 | 786 | 0.050 |
Why?
| | Middle Aged | 4 | 2015 | 31154 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2005 | 268 | 0.050 |
Why?
| | Prospective Studies | 3 | 2023 | 7133 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2023 | 162 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 286 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 3144 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 162 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1368 | 0.050 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 442 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 793 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1040 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2007 | 1098 | 0.040 |
Why?
| | Hypertension | 1 | 2007 | 1242 | 0.040 |
Why?
| | Colorado | 3 | 2013 | 4421 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 10230 | 0.030 |
Why?
| | Medicine | 1 | 2016 | 119 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 975 | 0.030 |
Why?
| | Education | 1 | 2013 | 101 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 221 | 0.020 |
Why?
| | Young Adult | 1 | 2008 | 12426 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 216 | 0.020 |
Why?
| | Comprehension | 1 | 2013 | 165 | 0.020 |
Why?
| | Medical Audit | 1 | 2011 | 77 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2013 | 717 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 161 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 201 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2013 | 7086 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 738 | 0.020 |
Why?
| | Self Care | 1 | 2013 | 370 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2011 | 137 | 0.020 |
Why?
| | Self Efficacy | 1 | 2013 | 374 | 0.020 |
Why?
| | Sepsis | 1 | 2015 | 574 | 0.020 |
Why?
| | Training Support | 1 | 2008 | 28 | 0.020 |
Why?
| | Palliative Care | 1 | 2015 | 725 | 0.020 |
Why?
| | Work Schedule Tolerance | 1 | 2005 | 42 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2005 | 608 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2717 | 0.010 |
Why?
|
|
Glasheen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|